Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu, PR China ; State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, PR China.
State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, PR China.
Cell Biosci. 2014 Nov 25;4:71. doi: 10.1186/2045-3701-4-71. eCollection 2014.
Ceramides are a class of sphingolipids that form the structural component of the cell membrane and also act as second messengers in cell signaling pathways. Emerging results suggest that ceramide induces growth arrest and apoptosis in various human cancer cells. However, the mechanisms underlying its antitumor activity are yet to be identified. Endoplasmic reticulum stress (ER stress), a cellular adaptive response, is believed to initially compensate for damage but can eventually trigger cell death if the stimulus is severe or prolonged. In this study, we investigated whether ceramide induces cell death in human salivary adenoid cystic carcinoma (ACCs) through activation of the apoptotic ER stress.
RT-PCR, real-time PCR and western blot demonstrated that exogenous ceramide treatment up-regulated GRP78 and p-eIF2α expression and XBP1 splicing. Moreover, the ceramide synthase inhibitor FB1 abolished ceramide-induced ER stress. Up-regulation of the ER stress-associated apoptosis promoting transcription factor CHOP and p-JNK suggested that the antitumor activity of ceramide is owing to activation of apoptotic ER stress. Mechanistically, [Ca(2+)]ER depletion and SERCA inhibition by ceramide treatment suggested that it induces ER stress by disrupting [Ca(2+)]ER homeostasis. The chemical chaperone TUDCA inhibited ceramide-induced ER stress and cell death. In addition, the downstream metabolite of ceramide, S1P, cannot activate ER stress.
These results demonstrated that exogenous ceramide induces cancer cell death through a mechanism involving severe ER stress triggered by the disruption of ER Ca(2+) homeostasis.
神经酰胺是一类鞘脂,构成细胞膜的结构成分,也作为细胞信号通路中的第二信使。新出现的结果表明,神经酰胺可诱导各种人类癌细胞的生长停滞和凋亡。然而,其抗肿瘤活性的机制尚待确定。内质网应激(ER 应激)是一种细胞适应性反应,最初被认为可以补偿损伤,但如果刺激严重或持续时间长,最终可能会引发细胞死亡。在这项研究中,我们研究了神经酰胺是否通过激活凋亡性 ER 应激诱导人涎腺腺样囊性癌(ACC)中的细胞死亡。
RT-PCR、实时 PCR 和 Western blot 表明,外源性神经酰胺处理上调了 GRP78 和 p-eIF2α 的表达和 XBP1 的剪接。此外,神经酰胺合酶抑制剂 FB1 消除了神经酰胺诱导的 ER 应激。ER 应激相关凋亡促进转录因子 CHOP 和 p-JNK 的上调表明,神经酰胺的抗肿瘤活性归因于激活凋亡性 ER 应激。机制上,神经酰胺处理导致[Ca(2+)]ER 耗竭和 SERCA 抑制,表明其通过破坏[Ca(2+)]ER 稳态诱导 ER 应激。化学伴侣 TUDCA 抑制了神经酰胺诱导的 ER 应激和细胞死亡。此外,神经酰胺的下游代谢产物 S1P 不能激活 ER 应激。
这些结果表明,外源性神经酰胺通过破坏 ER Ca(2+)稳态引发严重的 ER 应激诱导癌细胞死亡。